1. Home
  2. LUCD vs FNGR Comparison

LUCD vs FNGR Comparison

Compare LUCD & FNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUCD
  • FNGR
  • Stock Information
  • Founded
  • LUCD 2018
  • FNGR 2016
  • Country
  • LUCD United States
  • FNGR Singapore
  • Employees
  • LUCD N/A
  • FNGR N/A
  • Industry
  • LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FNGR Computer Software: Prepackaged Software
  • Sector
  • LUCD Health Care
  • FNGR Technology
  • Exchange
  • LUCD Nasdaq
  • FNGR Nasdaq
  • Market Cap
  • LUCD 108.0M
  • FNGR 96.2M
  • IPO Year
  • LUCD 2021
  • FNGR N/A
  • Fundamental
  • Price
  • LUCD $1.20
  • FNGR $1.53
  • Analyst Decision
  • LUCD Strong Buy
  • FNGR
  • Analyst Count
  • LUCD 5
  • FNGR 0
  • Target Price
  • LUCD $3.70
  • FNGR N/A
  • AVG Volume (30 Days)
  • LUCD 1.3M
  • FNGR 357.3K
  • Earning Date
  • LUCD 11-12-2025
  • FNGR 10-14-2025
  • Dividend Yield
  • LUCD N/A
  • FNGR N/A
  • EPS Growth
  • LUCD N/A
  • FNGR N/A
  • EPS
  • LUCD N/A
  • FNGR N/A
  • Revenue
  • LUCD $4,360,000.00
  • FNGR $35,881,122.00
  • Revenue This Year
  • LUCD $13.90
  • FNGR N/A
  • Revenue Next Year
  • LUCD $163.88
  • FNGR N/A
  • P/E Ratio
  • LUCD N/A
  • FNGR N/A
  • Revenue Growth
  • LUCD 14.74
  • FNGR 15.09
  • 52 Week Low
  • LUCD $0.75
  • FNGR $1.03
  • 52 Week High
  • LUCD $1.80
  • FNGR $5.20
  • Technical
  • Relative Strength Index (RSI)
  • LUCD 55.37
  • FNGR 44.46
  • Support Level
  • LUCD $1.17
  • FNGR $1.45
  • Resistance Level
  • LUCD $1.27
  • FNGR $1.58
  • Average True Range (ATR)
  • LUCD 0.08
  • FNGR 0.16
  • MACD
  • LUCD 0.01
  • FNGR -0.03
  • Stochastic Oscillator
  • LUCD 73.08
  • FNGR 10.00

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

About FNGR FingerMotion Inc.

FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.

Share on Social Networks: